231 related articles for article (PubMed ID: 33735360)
21. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
23. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
[TBL] [Abstract][Full Text] [Related]
24. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.
Powers TW; Holst S; Wuhrer M; Mehta AS; Drake RR
Biomolecules; 2015 Oct; 5(4):2554-72. PubMed ID: 26501333
[TBL] [Abstract][Full Text] [Related]
25. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
26. Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues.
Holst S; Heijs B; de Haan N; van Zeijl RJ; Briaire-de Bruijn IH; van Pelt GW; Mehta AS; Angel PM; Mesker WE; Tollenaar RA; Drake RR; Bovée JV; McDonnell LA; Wuhrer M
Anal Chem; 2016 Jun; 88(11):5904-13. PubMed ID: 27145236
[TBL] [Abstract][Full Text] [Related]
27. In Situ Imaging of N-Glycans by MALDI Imaging Mass Spectrometry of Fresh or Formalin-Fixed Paraffin-Embedded Tissue.
Drake RR; Powers TW; Norris-Caneda K; Mehta AS; Angel PM
Curr Protoc Protein Sci; 2018 Nov; 94(1):e68. PubMed ID: 30074304
[TBL] [Abstract][Full Text] [Related]
28. MALDI Imaging Mass Spectrometry of N-glycans and Tryptic Peptides from the Same Formalin-Fixed, Paraffin-Embedded Tissue Section.
Angel PM; Mehta A; Norris-Caneda K; Drake RR
Methods Mol Biol; 2018; 1788():225-241. PubMed ID: 29058228
[TBL] [Abstract][Full Text] [Related]
29. Negative Ion-Mode N-Glycan Mass Spectrometry Imaging by MALDI-2-TOF-MS.
Soltwisch J; Heijs B
Methods Mol Biol; 2023; 2688():173-186. PubMed ID: 37410293
[TBL] [Abstract][Full Text] [Related]
30. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
31. An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry.
Wallace EN; West CA; McDowell CT; Lu X; Bruner E; Mehta AS; Aoki-Kinoshita KF; Angel PM; Drake RR
Sci Rep; 2024 Jan; 14(1):489. PubMed ID: 38177192
[TBL] [Abstract][Full Text] [Related]
32. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
33. On-MALDI-Target N-Glycan Nonreductive Amination by 2-Aminobenzoic Acid.
Hronowski XL; Wang Y; Sosic Z; Wei R
Anal Chem; 2020 Aug; 92(15):10252-10256. PubMed ID: 32628832
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of isomeric N-glycan structures by normal-phase liquid chromatography-MALDI-TOF/TOF tandem mass spectrometry.
Maslen S; Sadowski P; Adam A; Lilley K; Stephens E
Anal Chem; 2006 Dec; 78(24):8491-8. PubMed ID: 17165844
[TBL] [Abstract][Full Text] [Related]
35. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry.
Drake RR; McDowell C; West C; David F; Powers TW; Nowling T; Bruner E; Mehta AS; Angel PM; Marlow LA; Tun HW; Copland JA
J Mass Spectrom; 2020 Apr; 55(4):e4490. PubMed ID: 31860772
[TBL] [Abstract][Full Text] [Related]
36. High throughput quantification of N-glycans using one-pot sialic acid modification and matrix assisted laser desorption ionization time-of-flight mass spectrometry.
Gil GC; Iliff B; Cerny R; Velander WH; Van Cott KE
Anal Chem; 2010 Aug; 82(15):6613-20. PubMed ID: 20586471
[TBL] [Abstract][Full Text] [Related]
37. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
38. Characterization of N-glycome profile in mouse brain tissue regions by MALDI-TOF/MS.
Liu Y; Han Y; Zhu W; Luo Q; Yuan J; Liu X
Anal Bioanal Chem; 2023 Sep; 415(23):5575-5588. PubMed ID: 37452841
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
40. Spatial N-glycomics of the normal breast microenvironment reveals fucosylated and high-mannose N-glycan signatures related to BI-RADS density and ancestry.
Rujchanarong D; Spruill L; Sandusky GE; Park Y; Mehta AS; Drake RR; Ford ME; Nakshatri H; Angel PM
Glycobiology; 2024 Jun; 34(8):. PubMed ID: 38869882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
